在COVID-19大流行之前和期间,儿童医院的支气管炎入院人数
Kailey A Remien1, Justin Z Amarin2, Christopher M Horvat3
1Department of Medical Education, Akron Children's Hospital, Akron, Ohio.
JAMA network open
|October 26, 2023
概括
支气管炎住院病例在COVID-19大流行期间减少,然后随着季节性变化而显著增加. 入院的患者年龄较大,入院重症监护室 (ICU) 患者更多,这表明从大流行前的模式转变.
科学领域:
- 儿科 儿科 儿科
- 流行病学 流行病学
- 传染性疾病 传染性疾病
背景情况:
- COVID-19大流行影响了呼吸道病毒的季节性,但其对支气管炎入院的影响超出初始观察仍然不清楚.
- 了解当前的趋势对于医疗保健资源分配和患者管理至关重要.
研究的目的:
- 分析2020-2023赛季美国儿童医院支气管炎入院模式的变化,与2010-2019年大流行前时期相比.
- 评估疫情期间患者人口统计和重症监护室 (ICU) 使用情况的变化.
主要方法:
- 使用美国41家儿童医院的儿科健康信息系统数据库进行了回顾性横截面研究.
- 从2010年7月到2023年6月,分析了2岁以下患者的支气管炎入院情况.
- 流行病时代 (2020-2023) 的入院人数与流行病前 (2010-2020) 的预测相比较.
主要成果:
- 总支气管炎入院病例在2020-2021年下降了69.2%,但与大流行前水平相比,在2022-2023年增加了75.3%.
- 流行病时期的患者年龄较大 (中位数为7个月与6个月),并有更高的ICU入院率 (36.7%与32.2%).
- 支气管炎的季节性转移,入院率在2021年和2022年的典型冬季月份之外达到顶峰.
结论:
- 支气管炎住院患者的数量短暂下降,随后在COVID-19大流行期间显著增加.
- 支气管炎的季节性并没有恢复到大流行前的模式,需要持续的监测和准备.
- 医疗保健系统应该预测持续的非典型支气管炎趋势和儿科呼吸道感染的潜在激增.
更多相关视频
相关概念视频
Pneumonia I: Introduction
248
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
248
Pulmonary Cycle: Exhalation
1.6K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Acute Respiratory Failure-II
249
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
249
Acute Respiratory Failure-I
220
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
220
Acute Respiratory Failure-V
143
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
143
Transmission-based Precautions II: Airborne and Protective Environment
1.3K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.3K


